Case File №
#VI-2026-0133
Advanced Technology and Industrial
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
43 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Tirzepatide | X Unrated | 1 | 5.6 | 5.6 | 5.6 | 25 May 2026 |
| 1-Testosterone Cypionate (DHB) Raw | X N/A | 1 | 4.0 | 1.7 | 1.7 | 2 Jul 2025 |
| 5-amino-1MQ | X N/A | 1 | 4.0 | 0.0 | 0.0 | 2 Jul 2025 |
| Abaloparatide | X N/A | 1 | 4.0 | 0.0 | 0.0 | 21 May 2025 |
| ACE-031 | X N/A | 1 | 4.0 | 0.4 | 0.4 | 2 Apr 2025 |
| AHK-CU | X N/A | 1 | 4.0 | 1.0 | 1.0 | 20 Jun 2025 |
| Anavar (Oxandrolone) | X N/A | 1 | 4.0 | 0.0 | 0.0 | 14 Jan 2025 |
| ARA-290 | X N/A | 1 | 4.0 | 0.0 | 0.0 | 25 Apr 2025 |
| Botulinum toxin | X N/A | 1 | 4.0 | 0.3 | 0.3 | 28 Mar 2025 |
| Cerebrolysin | X N/A | 1 | 4.0 | 0.1 | 0.1 | 14 Jan 2025 |
| CJC-1295 With DAC | X N/A | 1 | 4.0 | 0.0 | 0.0 | 3 Jul 2025 |
| CJC-1295 w/o DAC 5mg + IPA 5mg Blend | X N/A | 1 | 4.0 | 0.6 | 0.6 | 24 Apr 2025 |
| Clenbuterol | X N/A | 1 | 4.0 | 0.0 | 0.0 | 9 Jun 2025 |
| Crystagen | X N/A | 1 | 4.0 | 0.0 | 0.0 | 8 Jul 2025 |
| Dianabol Oil | X N/A | 1 | 4.0 | 0.0 | 0.0 | 8 Jul 2025 |
| Dihexa | X N/A | 1 | 4.0 | 0.6 | 0.6 | 9 Jun 2025 |
| Dutasteride | X N/A | 1 | 4.0 | 0.0 | 0.0 | 7 May 2025 |
| GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | X N/A | 1 | 4.0 | 0.0 | 0.0 | 14 Jan 2025 |
| Hyaluronic acid | X N/A | 1 | 4.0 | 1.3 | 1.3 | 17 Dec 2024 |
| KPV Oral | X N/A | 1 | 4.0 | 0.5 | 0.5 | 28 Mar 2025 |
| LGD-4033 (Ligandrol) | X N/A | 1 | 4.0 | 1.5 | 1.5 | 2 Apr 2025 |
| Lipo-C FOCUS 425mg | X N/A | 1 | 4.0 | 3.1 | 3.1 | 2 Jul 2025 |
| Liraglutide | X N/A | 1 | 4.0 | 0.0 | 0.0 | 28 Mar 2025 |
| MT-1 | X N/A | 1 | 4.0 | 0.0 | 0.0 | 21 May 2025 |
| NAD+ Injectable | X N/A | 1 | 4.0 | 0.0 | 0.0 | 2 Apr 2025 |
| Orforglipron | X N/A | 1 | 4.0 | 1.5 | 1.5 | 3 Jun 2025 |
| Ostarine (MK-2866) | X N/A | 1 | 4.0 | 0.6 | 0.6 | 16 Mar 2025 |
| Oxytocin Acetate | X N/A | 1 | 4.0 | 0.1 | 0.1 | 2 Jul 2025 |
| PE 22-28 | X N/A | 1 | 4.0 | 1.3 | 1.3 | 21 May 2025 |
| Prednisone | X N/A | 1 | 4.0 | 0.0 | 0.0 | 14 Jan 2025 |
| PTD-DBM | X N/A | 1 | 4.0 | 0.0 | 0.0 | 14 Jan 2025 |
| RIPEX 225 (TRA/Mast P/Test P) | X N/A | 1 | 4.0 | 0.0 | 0.0 | 16 Mar 2025 |
| Selank 10mg + Semax 10mg Blend | X N/A | 1 | 4.0 | 0.0 | 0.0 | 9 Jun 2025 |
| Semax | X N/A | 1 | 4.0 | 0.0 | 0.0 | 3 Jun 2025 |
| SLU-PP-332 250mcg + BAM15 50mcg Blend | X N/A | 1 | 4.0 | 0.0 | 0.0 | 20 Jun 2025 |
| SS-31 | X N/A | 1 | 4.0 | 0.0 | 0.0 | 24 Apr 2025 |
| Tadalafil Raw | X N/A | 1 | 4.0 | 0.0 | 0.0 | 3 Jul 2025 |
| Tamoxifen (Nolvadex) | X N/A | 1 | 4.0 | 0.5 | 0.5 | 2 Jul 2025 |
| Trenbolone Acetate | X N/A | 1 | 4.0 | 1.7 | 1.7 | 13 Feb 2025 |
| Trestolone Acetate (MENT) Raw | X N/A | 1 | 4.0 | 0.0 | 0.0 | 17 Dec 2024 |
| TriTren 225 | X N/A | 1 | 4.0 | 0.0 | 0.0 | 7 May 2025 |
| Vilon | X N/A | 1 | 4.0 | 0.0 | 0.0 | 11 Jun 2025 |
| Winstrol (Stanozolol) | X N/A | 1 | 4.0 | 0.0 | 0.0 | 24 Apr 2025 |
Exhibit II
Evidence Log
42 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | AHK-CU | 4.0 C | 30mg | 32.5mg | +8.5% | 96.04% | ya0npa | Lab G | Public |
| 25 May 2026 | Anavar (Oxandrolone) | 4.7 C | 100mg | 109.1mg | +9.1% | 96.12% | 0ifl8r | Lab C | Public |
| 24 May 2026 | SS-31 | 4.8 C | 20mg | 24.9mg | +24.5% | 95.08% | 994voc | Lab B | Public |
| 24 May 2026 | Trestolone Acetate (MENT) Raw | 4.2 C | 500g | 581.3g | +16.3% | 95.90% | 9i7a56 | Lab G | Community |
| 24 May 2026 | Vilon | 4.0 C | 10mg | 10.8mg | +7.6% | 97.88% | wov05h | Lab E | Public |
| 24 May 2026 | Tamoxifen (Nolvadex) | 4.0 C | 25mg | 30.7mg | +22.7% | 98.96% | awirw8 | Lab G | Community |
| 24 May 2026 | Trenbolone Acetate | 4.0 C | 100mg/ml | 101.2mg/ml | +1.2% | 95.95% | tewndh | Lab A | Public |
| 24 May 2026 | ARA-290 | 5.5 B | 50mg | 54.1mg | +8.2% | 95.07% | 0kyteb | Lab A | Community |
| 24 May 2026 | Clenbuterol | 4.1 C | 50mg | 43.7mg | -12.6% | 96.25% | 9oe2mz | Lab F | Public |
| 24 May 2026 | Prednisone | 6.7 A | 10mg | 12.0mg | +20.0% | 97.36% | kzl9p6 | Lab G | Community |
| 24 May 2026 | SLU-PP-332 250mcg + BAM15 50mcg Blend | 4.0 C | 10mg | 8.6mg | -14.2% | 98.79% | hcwxup | Lab F | Community |
| 23 May 2026 | Dianabol Oil | 4.0 C | 300mg/ml | 282.8mg/ml | -5.7% | 98.45% | 2c8tbn | Lab E | Community |
| 21 May 2026 | Cerebrolysin | 4.7 C | 50mg | 55.2mg | +10.5% | 96.78% | tt9vbj | Lab B | Community |
| 21 May 2026 | ACE-031 | 4.6 C | 15mg | 15.6mg | +4.3% | 98.10% | g2ywli | Lab B | Community |
| 21 May 2026 | Botulinum toxin | 4.0 C | 10mg | 11.3mg | +13.0% | 95.04% | hzrd8m | Lab E | Community |
| 19 May 2026 | Lipo-C FOCUS 425mg | 6.3 A | 300mg/ml | 372.2mg/ml | +24.1% | 96.02% | 94bxs3 | Lab D | Community |
| 19 May 2026 | TriTren 225 | 4.0 C | 300mg/ml | 325.2mg/ml | +8.4% | 96.73% | 0z5eml | Lab B | Community |
| 17 May 2026 | Crystagen | 4.0 C | 15mg | 17.8mg | +18.6% | 99.26% | 18xenf | Lab G | Community |
| 17 May 2026 | Liraglutide | 4.0 C | 20mg | 18.1mg | -9.4% | 98.77% | xs8vmk | Lab G | Public |
| 17 May 2026 | NAD+ Injectable | 4.0 C | 200mg/ml | 249.2mg/ml | +24.6% | 99.72% | 0lgeoy | Lab E | Public |
| 29 Jan 2026 | PE 22-28 | 4.8 C | 5mg | 6.1mg | +21.7% | 96.53% | 7jxcij | Lab A | Public |
| 26 Jan 2026 | LGD-4033 (Ligandrol) | 4.9 C | 25mg | 29.6mg | +18.6% | 95.33% | aj7g3p | Lab A | Public |
| 26 Jan 2026 | Winstrol (Stanozolol) | 4.0 C | 25mg | 25.5mg | +2.1% | 96.64% | zew6yg | Lab G | Public |
| 19 Jan 2026 | 1-Testosterone Cypionate (DHB) Raw | 4.0 C | 1g | 1.1g | +12.3% | 99.09% | iq0fq7 | Lab B | Public |
| 19 Jan 2026 | Abaloparatide | 4.0 C | 20mg | 17.6mg | -11.9% | 96.50% | t2pafh | Lab A | Public |
| 19 Jan 2026 | Oxytocin Acetate | 4.0 C | 50mg | 49.6mg | -0.8% | 96.53% | v4lpgd | Lab B | Public |
| 9 Jan 2026 | RIPEX 225 (TRA/Mast P/Test P) | 4.8 C | 100mg/ml | 120.9mg/ml | +20.9% | 95.13% | rw62oe | Lab C | Public |
| 7 Jan 2026 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 4.0 C | 5mg | 5.0mg | +0.8% | 99.06% | gfcnji | Lab F | Public |
| 7 Jan 2026 | PTD-DBM | 4.0 C | 30mg | 36.5mg | +21.8% | 98.79% | l56a4j | Lab G | Community |
| 5 Dec 2025 | Hyaluronic acid | 4.0 C | 15mg | 13.8mg | -7.9% | 95.08% | tx60qs | Lab C | Community |
| 5 Dec 2025 | Semax | 4.0 C | 10mg | 12.1mg | +20.9% | 98.17% | 0fu23a | Lab E | Community |
| 23 Nov 2025 | Tadalafil Raw | 5.5 B | 500g | 459.3g | -8.1% | 95.74% | li2m41 | Lab A | Public |
| 17 Nov 2025 | KPV Oral | 4.0 C | 50mg | 57.8mg | +15.6% | 95.49% | 0l879f | Lab G | Community |
| 5 Nov 2025 | MT-1 | 4.0 C | 30mg | 26.4mg | -11.9% | 98.27% | cxdg5x | Lab B | Public |
| 5 Nov 2025 | Ostarine (MK-2866) | 4.0 C | 20mg | 20.3mg | +1.6% | 98.81% | 75vu0r | Lab G | Public |
| 4 Nov 2025 | 5-amino-1MQ | 4.8 C | 50mg | 43.3mg | -13.4% | 97.38% | 9h8hvs | Lab A | Public |
| 4 Nov 2025 | CJC-1295 With DAC | 4.0 C | 5mg | 5.5mg | +9.4% | 98.05% | tsm1n5 | Lab D | Community |
| 17 Oct 2025 | Orforglipron | 4.4 C | 100mg | 89.7mg | -10.3% | 99.13% | i6g57o | Lab D | Public |
| 17 Oct 2025 | Selank 10mg + Semax 10mg Blend | 4.4 C | 10mg | 8.7mg | -13.1% | 95.90% | 14zud1 | Lab B | Community |
| 9 Oct 2025 | Dihexa | 5.1 B | 20mg | 24.7mg | +23.6% | 99.20% | cj7gd0 | Lab E | Public |
| 9 Oct 2025 | Dutasteride | 4.0 C | 100mg | 89.6mg | -10.4% | 96.90% | 4yvlz1 | Lab G | Community |
| 3 Oct 2025 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 5.1 B | 20mg | 19.0mg | -5.0% | 95.54% | c1ejkd | Lab G | Public |
— END OF EVIDENCE LOG —